Search Discussions
View Discussions Replied ToDiscussions Started
Blazena Kaderabkova replied Aug 26, 2013 to Ataluren - phase III
Blazena Kaderabkova replied Feb 20, 2013 to Ataluren Webinar
Blazena Kaderabkova replied Jan 29, 2013 to Ataluren Webinar
Blazena Kaderabkova replied Jun 9, 2012 to ATALUREN - confused about the information given from PTC Therapeutics and Genzyme
Blazena Kaderabkova replied Jun 7, 2012 to ATALUREN - confused about the information given from PTC Therapeutics and Genzyme
Blazena Kaderabkova replied Jun 2, 2012 to ATALUREN - confused about the information given from PTC Therapeutics and Genzyme
Blazena Kaderabkova replied May 9, 2012 to Walking change
Blazena Kaderabkova replied Mar 23, 2012 to Six Month Study of Gentamicin in Duchenne Muscular Dystrophy With Stop Codons
Blazena Kaderabkova replied Feb 6, 2012 to One year on Phase 2 of GSX/Prosensa Trial
Blazena Kaderabkova replied Jan 5, 2012 to Halo Therapeutics' HT-100 Receives FDA's Orphan Designation for Duchenne Muscular Dystrophy
RSS
Welcome toPPMD Community
Sign Upor Sign In
Or sign in with:
Need help using this community site? Visit Ning's Help Page.
Terms of Service
© 2023 Created by PPMD. Powered by
Badges | Report an Issue | Privacy Policy | Terms of Service
Please check your browser settings or contact your system administrator.